SHAFIT produces live and inactivated single and combination
vaccines that help in the control of all known infectious poultry
diseases.
Employees: 50
Market regions:
Far East, South America, Africa, Eastern Europe
Main Markets:
Asia, Eastern Europe, Africa
Overview
SHAFIT was established in 1990 by Kibbutz Shefayim and private
Expertise
SPF eggs incubation technique, cell cultures, cell lines, Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
entrepreneurs. The company specializes in the production of a
variety of veterinary vaccines for poultry. The vaccines are made
from modified live viruses and inactivated bacteria or viruses in
oil emulsions and other adjuvants. Within the short period of
time from the beginning of the company, SHAFIT has rapidly become
a major producer of vaccines for the highly advanced Israeli
poultry industry.
The plant encompasses the following facilities:
* Live Vaccine Production Laboratories
* Inactivated Vaccine Production Laboratories
* Quality Assurance and Control Laboratory
* Bacteriological Research Laboratory (R&D)
* Virological Research Laboratory (R&D)
* In-house animal facilities for Quality Assurance and Control
and R&D animal trials
SHAFIT's laboratories are designed and equipped to meet the
specific needs and modern requirements for vaccine production.
The managerial and scientific veterinary staff have extensive
experience in the field. The company's standards (potency,
purity, efficacy and safety) conform to the highest international
and Israeli standards. SHAFIT has approval for ISO 9002
standardization and is conforming its facilities to GMP
standards.
cloning, immunological methods elisa, AGP serum neutralization
and PCR
R&D technology:
Biotechnological solutions to veterinary diseases.
R&D applications:
Biotechnological, Genetic Engineering
R&D markets:
Breeders, Veterinarians, Meat & Poultry Food Production
Sci. discipline:
Veterinary Medicine, Microbiology, Genetic Engineering and Biotechnology
Available R&D facilities
Annual R&D expenditure (MU$): 600
R&D employees: 5
R&D professionals: 5
Equipment:
Bacteriological and Virological Research Laboratories including advanced equipment for research and development of different types of vaccine production.
